Ras al Khaimah - June 30, 2010 - An operator holds a basket of tablets of the Type 1 Diabetes medicine Dialon in Gulf Pharmaceuticals Julphar in Ras al Khaimah, June 30, 2010. (Photo by Jeff Topping/The National)
Julphar attributed losses to temporary suspension in the export of medicines to Saudi Arabia, Oman, Bahrain and Kuwait as well as product recalls due to quality issues. Jeff Topping / The National

Julphar chief executive steps down as company faces mounting pressure

Energy This Week

Expert analysis on oil & gas renewables and clean energy

      By signing up, I agree to The National's privacy policy
      Energy This Week